GSK plc
F:GS70
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GSK plc
F:GS70
|
UK |
|
U
|
UnitedHealth Group Inc
XMUN:UNH
|
US |
|
M
|
Medifast Inc
DUS:MDF
|
US |
|
T
|
TotalEnergies SE
XHAM:TOTB
|
FR |
|
L
|
Lundin Mining Corp
XBER:GXD
|
CA |
|
K
|
Keyence Corp
SWB:KEE
|
JP |
|
C
|
CF Industries Holdings Inc
DUS:C4F
|
US |
|
T
|
Tencent Holdings Ltd
XMUN:NNND
|
CN |
|
H
|
Heidelberg Pharma AG
F:HPHA
|
DE |
|
Grupo Aeroportuario del Sureste SAB de CV
F:AEDA
|
MX |
|
China Petroleum & Chemical Corp
F:CHU
|
CN |
|
V
|
Viasat Inc
DUS:VS1
|
US |
|
C
|
Credit Agricole SA
LSE:0HAI
|
FR |
Wall St Price Targets
GS70 Price Targets Summary
GSK plc
According to Wall Street analysts, the average 1-year price target for GS70 is 46.63 EUR with a low forecast of 32.91 EUR and a high forecast of 64.67 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GS70's stock price target?
Price Target
46.63
EUR
According to Wall Street analysts, the average 1-year price target for GS70 is 46.63 EUR with a low forecast of 32.91 EUR and a high forecast of 64.67 EUR.
What is the Revenue forecast for GSK plc?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for GSK plc?
Projected CAGR
1%
Over the last 14 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 8 years is 1%.
What is the Net Income forecast for GSK plc?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 8 years is 4%.
